Pasaoglu, G. Et Al. 2006. Does the combination of inhaled steroids with long acting beta2 agonists decrease the risk for osteoporosis? A 1-year prospective follow-up study.. Rheumatology international , vol.27, no.2 , 141-6.

Pasaoglu, G., GÖK, H., Mungan, D., Sonel, B., Yalcin, P., & Misirligil, Z., (2006). Does the combination of inhaled steroids with long acting beta2 agonists decrease the risk for osteoporosis? A 1-year prospective follow-up study.. Rheumatology international , vol.27, no.2, 141-6.

Pasaoglu, Gulden Et Al. "Does the combination of inhaled steroids with long acting beta2 agonists decrease the risk for osteoporosis? A 1-year prospective follow-up study.," Rheumatology international , vol.27, no.2, 141-6, 2006

Pasaoglu, Gulden Et Al. "Does the combination of inhaled steroids with long acting beta2 agonists decrease the risk for osteoporosis? A 1-year prospective follow-up study.." Rheumatology international , vol.27, no.2, pp.141-6, 2006

Pasaoglu, G. Et Al. (2006) . "Does the combination of inhaled steroids with long acting beta2 agonists decrease the risk for osteoporosis? A 1-year prospective follow-up study.." Rheumatology international , vol.27, no.2, pp.141-6.

@article{article, author={Gulden Pasaoglu Et Al. }, title={Does the combination of inhaled steroids with long acting beta2 agonists decrease the risk for osteoporosis? A 1-year prospective follow-up study.}, journal={Rheumatology international}, year=2006, pages={141-6} }